Syngen Biotech Co.,Ltd. Syngen Biotech Co.,Ltd.

Syngen Biotech Co.,Ltd.

8279

Rank in Stocks #21455
Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd.... Established in 1988 and based in Tainan City, Taiwan, Syngen Biotech Co.,Ltd. operates globally, including in Taiwan and China, specializing in the research, development, production, and sale of a diverse array of products. Its core offerings include microbial pharmaceutical raw materials, biological pesticides, fertilizers, biochemical nutritional products, and preventive medicines. The company further manufactures dietary supplements and provides comprehensive contract manufacturing services for supplements, accommodating various formats such as sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies. Syngen Biotech also develops and markets science-backed bioactive pharmaceutical ingredients (APIs) under proprietary brands including Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL. Additional services encompass private labelling, organic food OEM/ODM, explosion-proof extraction, brand agency, and wholesale distribution. Syngen Biotech caters to numerous industries, such as sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox. The company actively exports its products to approximately 20 countries worldwide.
Share Price
$2.35
Last synced: 2026-11-20
Market Cap
$63.47M
Change (1 day)
-2.66%
Change (1 year)
-44.90%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Syngen Biotech Co.,Ltd. (8279)
EPS as of September 2026 TTM: $0.23
According to Syngen Biotech Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $0.23. At the end of 2025 the company had an EPS of $0.32, an increase over its 2024 EPS of $0.27.
EPS history for Syngen Biotech Co.,Ltd. from 2019 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.23 -28.06%
2025 $0.32 18.30%
2024 $0.27 -18.34%
2023 $0.33 -14.49%
2022 $0.39 22.16%
2021 $0.32 11.80%
2020 $0.28 7.69%
2019 $0.26 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 6,702.78%
US
$-7.08 -3,175.59%
US
$-5.29 -2,398.00%
AU
$21.56 9,265.77%
NL
$12.73 5,430.93%
BE

Questions about Syngen Biotech Co.,Ltd.'s earnings per share (EPS)

What is Syngen Biotech Co.,Ltd.'s earnings per share (EPS)?

Syngen Biotech Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $0.23, as of Sep 2026.

What was Syngen Biotech Co.,Ltd.'s earnings per share (EPS) in 2025?

In 2025, Syngen Biotech Co.,Ltd.'s earnings per share (EPS) was $0.32, 18.52% more than in 2024 ($0.27).

How has Syngen Biotech Co.,Ltd.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Syngen Biotech Co.,Ltd.'s earnings per share (EPS) went from $0.28 to $0.32, an average growth of 2.71% a year.

How does Syngen Biotech Co.,Ltd.'s earnings per share (EPS) compare with similar companies?

Syngen Biotech Co.,Ltd.'s earnings per share (EPS) ($0.23) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.